EMPIRE BIO A/S
Credit rating
Company information
About EMPIRE BIO A/S
EMPIRE BIO A/S (CVR number: 12627343) is a company from KØBENHAVN. The company recorded a gross profit of 6139.6 kDKK in 2023. The operating profit was -271 kDKK, while net earnings were -210 kDKK. The profitability of the company measured by Return on Assets (ROA) was -3.4 %, which can be considered poor and Return on Equity (ROE) was -4.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 63.3 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. EMPIRE BIO A/S's liquidity measured by quick ratio was 0.8 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 10 820.62 | 6 733.64 | 6 071.77 | 6 158.89 | 6 139.57 |
EBIT | 4 359.59 | 621.09 | 201.88 | -82.32 | - 271.01 |
Net earnings | 3 334.56 | 451.62 | 125.29 | -84.64 | - 210.01 |
Shareholders equity total | 7 277.50 | 4 729.12 | 4 854.41 | 4 769.77 | 4 559.75 |
Balance sheet total (assets) | 10 203.93 | 12 336.68 | 10 989.72 | 8 739.08 | 7 421.99 |
Net debt | -2 245.65 | -6 139.38 | -4 343.84 | -2 547.65 | -1 270.87 |
Profitability | |||||
EBIT-% | |||||
ROA | 42.4 % | 5.5 % | 1.7 % | -0.8 % | -3.4 % |
ROE | 46.9 % | 7.5 % | 2.6 % | -1.8 % | -4.5 % |
ROI | 59.8 % | 10.0 % | 4.0 % | -1.7 % | -5.8 % |
Economic value added (EVA) | 3 293.80 | 229.26 | 228.91 | -88.33 | - 321.68 |
Solvency | |||||
Equity ratio | 72.7 % | 39.0 % | 45.1 % | 56.0 % | 63.3 % |
Gearing | 0.8 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.3 | 0.9 | 0.9 | 0.9 | 0.8 |
Current ratio | 1.4 | 0.9 | 0.9 | 1.0 | 0.8 |
Cash and cash equivalents | 2 306.35 | 6 139.38 | 4 343.84 | 2 547.65 | 1 270.87 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | A | BBB | BBB | BB | BB |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.